Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-6-30
pubmed:abstractText
Aberrant facial nerve regeneration syndrome is systematically studied by constructing a subjective questionnaire organized into pertinent domains (impairment of quality of life, social interactions, perception of self-appearance, visual function, and perception of problem severity) and by physical assessment of degree of involuntary palpebral fissure closure during routine facial movements using videotaping and a physicians' grading scale.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1529-4242
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
36-43
pubmed:dateRevised
2011-2-16
pubmed:meshHeading
pubmed-meshheading:15988245-Adult, pubmed-meshheading:15988245-Botulinum Toxins, Type A, pubmed-meshheading:15988245-Chronic Disease, pubmed-meshheading:15988245-Double-Blind Method, pubmed-meshheading:15988245-Facial Expression, pubmed-meshheading:15988245-Facial Muscles, pubmed-meshheading:15988245-Facial Nerve, pubmed-meshheading:15988245-Facial Paralysis, pubmed-meshheading:15988245-Factor Analysis, Statistical, pubmed-meshheading:15988245-Female, pubmed-meshheading:15988245-Humans, pubmed-meshheading:15988245-Interpersonal Relations, pubmed-meshheading:15988245-Male, pubmed-meshheading:15988245-Nerve Regeneration, pubmed-meshheading:15988245-Neuromuscular Agents, pubmed-meshheading:15988245-Pilot Projects, pubmed-meshheading:15988245-Quality of Life, pubmed-meshheading:15988245-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints.
pubmed:affiliation
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study